YSG Yatsen Holding Ltd Annual reports only
Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1819580 · Reporting currency CNY · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY26.7%
TTM net income YoY88.6%
TTM EPS YoY88.6%
Revenue 3-yr CAGR5.1%
Net income 3-yr CAGR—
Margins
Gross margin78.2%
Operating margin-4.3%
Net margin-1.9%
FCF margin-3.2%
EBITDA margin-3.5%
Returns
ROE-2.7%
ROA-2.1%
ROIC (approx.)-6.5%
Asset turnover1.10x
Leverage & solvency
Liabilities / assets22.0%
Debt / equity0.00x
Current ratio3.63x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.17x
Accruals ratio0.4%
Payout ratio—
Capex / revenue1.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: CNY | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 4.30B | 3.39B | 3.41B | 3.71B | 5.84B |
| Cost of revenue | 936.78M | 776.24M | 901.46M | 1.19B | 1.94B |
| Gross profit | 3.36B | 2.62B | 2.51B | 2.52B | 3.90B |
| R&D expense | 137.30M | 109.29M | 111.70M | 126.88M | 142.09M |
| SG&A expense | 303.63M | 444.37M | 500.94M | 720.41M | 941.35M |
| Operating income | -185.79M | -824.89M | -913.36M | -928.90M | -1.62B |
| Pretax income | -92.52M | -713.31M | -753.44M | -818.63M | -1.55B |
| Income tax | -108,000 | -3.09M | -3.21M | 2.71M | -921,000 |
| Net income | -80.87M | -708.17M | -747.76M | -815.37M | -1.54B |
| EBITDA | -148.92M | -786.90M | -859.67M | -814.85M | -1.49B |
| EPS (basic) | -0.04 | -0.35 | -0.34 | -0.34 | -0.61 |
| EPS (diluted) | -0.04 | -0.35 | -0.34 | -0.34 | -0.61 |
| Weighted avg. shares (diluted) | 1.86B | 2.03B | 2.20B | 2.37B | 2.53B |
| Banking | |||||
| Net interest income | 40.72M | 86.14M | 89.02M | 34.66M | 45.66M |
| Balance sheet | |||||
| Cash & equivalents | 765.38M | 817.39M | 836.89M | 1.51B | 3.14B |
| Short-term investments | 246.01M | 539.13M | 1.22B | 1.07B | — |
| Receivables | 220.87M | 214.56M | 198.85M | 200.84M | 355.84M |
| Inventory | 508.73M | 386.05M | 352.09M | 423.29M | 695.76M |
| Current assets | 2.23B | 2.35B | 2.95B | 3.51B | 4.56B |
| PP&E, net | 77.01M | 74.37M | 64.88M | 75.62M | 245.31M |
| Goodwill | 155.03M | 155.03M | 556.57M | 857.14M | 869.42M |
| Intangibles | 537.51M | 559.71M | 671.40M | 689.67M | 745.85M |
| Total assets | 3.85B | 3.97B | 5.01B | 5.86B | 7.27B |
| Current liabilities | 615.28M | 640.19M | 611.33M | 588.41M | 877.58M |
| Total liabilities | 846.34M | 867.85M | 821.24M | 800.13M | 1.26B |
| Shareholders' equity | 3.01B | 3.06B | 4.14B | 4.72B | 5.66B |
| Cash flow statement | |||||
| Operating cash flow | -94.66M | -243.67M | -107.44M | 136.21M | -1.02B |
| Capital expenditure | 42.06M | 52.74M | 43.65M | 50.78M | 141.43M |
| Free cash flow | -136.73M | -296.41M | -151.09M | 85.43M | -1.16B |
| Investing cash flow | 246.79M | 592.12M | -260.49M | -1.16B | -1.48B |
| Financing cash flow | -151.44M | -394.23M | -342.45M | -654.45M | -1.71M |
| Depreciation & amortization | 36.87M | 37.99M | 53.68M | 114.05M | 130.67M |
| Stock-based compensation | 59.03M | 91.17M | 77.50M | 340.86M | 530.44M |
| Share buybacks | 111.02M | 405.79M | 212.69M | 654.65M | 15.16M |
Free plan shows the latest 5 periods; Pro shows all 8 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· Amounts are in the company's reporting currency, CNY, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.